BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18651222)

  • 1. Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells.
    Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT
    Apoptosis; 2008 Sep; 13(9):1135-47. PubMed ID: 18651222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
    Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
    Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells.
    Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT
    Cell Physiol Biochem; 2009; 24(3-4):253-62. PubMed ID: 19710540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.
    Lee DH; Szczepanski MJ; Lee YJ
    J Cell Biochem; 2009 Apr; 106(6):1113-22. PubMed ID: 19229860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor and serum activate distinct pathways to inhibit the BH3 only protein BAD in prostate carcinoma LNCaP cells.
    Chao OS; Clément MV
    Oncogene; 2006 Jul; 25(32):4458-69. PubMed ID: 16767165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
    Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
    Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells.
    Moon DO; Park SY; Choi YH; Kim ND; Lee C; Kim GY
    Toxicon; 2008 Jan; 51(1):112-20. PubMed ID: 17936321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
    Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
    Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoma-derived growth factor regulates the bad-mediated apoptotic pathway and induction of vascular endothelial growth factor in stomach cancer cells.
    Lee KH; Choi EY; Kim MK; Lee SH; Jang BI; Kim TN; Kim SW; Kim SW; Song SK; Kim JR; Jung BC
    Oncol Res; 2010; 19(2):67-76. PubMed ID: 21302807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factors induce apoptosis as well as proliferation in LIM 1215 colon cancer cells.
    Fu P; Thompson JA; Leeding KS; Bach LA
    J Cell Biochem; 2007 Jan; 100(1):58-68. PubMed ID: 16888814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation.
    Mao J; Xu Z; Fang Y; Wang H; Xu J; Ye J; Zheng S; Zhu Y
    Cancer Sci; 2008 Nov; 99(11):2120-7. PubMed ID: 18823380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragalus saponins induce apoptosis via an ERK-independent NF-kappaB signaling pathway in the human hepatocellular HepG2 cell line.
    Auyeung KK; Law PC; Ko JK
    Int J Mol Med; 2009 Feb; 23(2):189-96. PubMed ID: 19148542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression.
    Serini S; Trombino S; Oliva F; Piccioni E; Monego G; Resci F; Boninsegna A; Picci N; Ranelletti FO; Calviello G
    Apoptosis; 2008 Sep; 13(9):1172-83. PubMed ID: 18679798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction.
    Oh HY; Lee EJ; Yoon S; Chung BH; Cho KS; Hong SJ
    Prostate; 2007 Jul; 67(10):1061-9. PubMed ID: 17469127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
    J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
    Weitsman GE; Weebadda W; Ung K; Murphy LC
    Breast Cancer Res Treat; 2009 Nov; 118(2):269-79. PubMed ID: 18941890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chimeric protein induces tumor cell apoptosis by delivering the human Bcl-2 family BH3-only protein Bad.
    Antignani A; Youle RJ
    Biochemistry; 2005 Mar; 44(10):4074-82. PubMed ID: 15751984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells.
    Kishima Y; Yoshida K; Enomoto H; Yamamoto M; Kuroda T; Okuda Y; Uyama H; Nakamura H
    Hepatogastroenterology; 2002; 49(48):1639-44. PubMed ID: 12397753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.